Should You Avoid Bio-Reference Laboratories Inc (BRLI)?
At the moment, there are dozens of gauges market participants can use to analyze the equity markets. A duo of the most under-the-radar are hedge fund and insider trading movement.
Bio Reference Laboratories Inc (BRLI)
Market is closed
Sector: Services-Medical Laboratories
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Discovery Group Michael Murphy And Daniel Donoghue | 0 | $0 | 0% | |
| 2. | Andromeda Capital Larry Motola | 0 | $0 | 0% | |
| 3. | Overland Advisors Gordy Holterman And Derek Dunn | 0 | $0 | 0% | |
| 4. | PDT Partners Peter Muller | 0 | $0 | 0% | |
| 5. | Tang Capital Management Kevin C. Tang | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $14.52 | 2,000 | Director | 2,000 | 2011-12-13 | Filing | |
| $14.31 | 2,000 | Officer, Director | 28,332 | 2011-12-12 | Filing | |
| $14.24 | 10,000 | Officer, Director | 375,138 | 2011-12-12 | Filing | |
| $14.68 | 5,000 | Large Shareholder, Officer, Director | 2,308,466 | 2011-12-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $29.40 | 20,000 | Officer, Director | 345,138 | 2013-09-13 | Filing | |
| $28.95 | 4,000 | Officer, Director | 11,132 | 2013-06-27 | Filing | |
| $28.75 | 2,000 | Officer, Director | 15,132 | 2013-06-26 | Filing | |
| $28.37 | 4,000 | Officer, Director | 17,132 | 2013-06-24 | Filing | |
| $28.99 | 2,000 | Officer, Director | 23,132 | 2013-01-10 | Filing |
Institutional Investors' Holdings
News See All
Quest Diagnostics Inc (DGX), Laboratory Corp. of America Holdings (LH): Why This Health Care Stock Is a Good Value
End market conditions aren't great for diagnostics information services company Quest Diagnostics Inc (NYSE:DGX), but that doesn't stop it from being a good value.
WuXi PharmaTech (Cayman) Inc. (ADR) (WX): Are Hedge Funds Right About This Stock?
In the eyes of many of your fellow readers, hedge funds are perceived as useless, old investment vehicles of an era lost to time.
What Hedge Funds Think About Genomic Health, Inc. (GHDX)
In the 21st century investor’s toolkit, there are plenty of indicators investors can use to monitor stocks. Some of the best are hedge fund and insider trading movement.
Is Novadaq Technologies Inc. (NVDQ) Going to Burn These Hedge Funds?
In the financial world, there are a multitude of gauges market participants can use to track their holdings. A couple of the best are hedge fund and insider trading sentiment.
Here is What Hedge Funds Think About Bio-Reference Laboratories Inc (BRLI)
Bio-Reference Laboratories Inc (NASDAQ:BRLI) was in 11 hedge funds' portfolio at the end of March. BRLI investors should be aware of a decrease in enthusiasm from smart money lately.
Hedge Funds Aren't Crazy About Genomic Health, Inc. (GHDX) Anymore
At the moment, there are plenty of methods shareholders can use to watch Mr. Market. A duo of the most underrated are hedge fund and insider trading activity.
Nordion Inc (USA) (NDZ): Insiders Aren't Crazy About It
To most traders, hedge funds are viewed as worthless, old financial tools of the past.
Hedge Funds Are Crazy About Bio-Reference Laboratories Inc (BRLI)
To most investors, hedge funds are seen as unimportant, old investment vehicles of years past.
Billionaire Hedge Funds
